Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
暂无分享,去创建一个
J. Neuberger | F. Nevens | D. Samuel | A. Jardine | W. Bechstein | B. Krämer | D. Serón | C. Duvoux | S. Schneeberger | N. Kamar | G. Tisone | T. van Gelder | H. Metselaar | D. Kuypers | P. Burra | F. Citterio | J. Pirenne | M. Rodríguez-Perálvarez | P. Trunečka | S. D. De Geest | P. Trunec̃ka
[1] C. Staatz,et al. Investigating barriers to immunosuppressant medication adherence in renal transplant patients , 2018, Nephrology.
[2] Byron H. Smith,et al. Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology , 2018, Transplantation direct.
[3] A. Cabrita,et al. Correlations between donor-specific antibodies and non-adherence with chronic active antibody-mediated rejection phenotypes and their impact on kidney graft survival. , 2018, Human immunology.
[4] F. Dobbels,et al. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] R. Annunziato,et al. Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] M. Dew,et al. Understanding Medication Nonadherence after Kidney Transplant. , 2017, Journal of the American Society of Nephrology : JASN.
[7] Lei Zhang,et al. Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review , 2017, Journal of Investigative Medicine.
[8] B. Décaudin,et al. Factors relevant to medication non-adherence in kidney transplant: a systematic review , 2017, International Journal of Clinical Pharmacy.
[9] K. Volpp,et al. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] A. Koenig,et al. Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs , 2016, Front. Immunol..
[11] Laura Lovato,et al. Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study , 2016, American Journal of Nephrology.
[12] M. Abecassis,et al. The impact of coronary artery disease on outcomes after liver transplantation , 2016, Journal of cardiovascular medicine.
[13] M. Arias,et al. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development , 2016, Transplantation.
[14] W. Weimar,et al. A high intrapatient variability in tacrolimus exposure is associated with poor long‐term outcome of kidney transplantation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[15] N. Kamar,et al. Donor-specific antibodies and liver transplantation. , 2016, Human immunology.
[16] E. Furth,et al. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] T. Vermeulen,et al. High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] L. Rostaing,et al. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study , 2016, Transplantation.
[19] B. Yard,et al. Optimized donor management and organ preservation before kidney transplantation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[20] L. Muñoz,et al. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice , 2016, Transplantation.
[21] D. Lloyd‐Jones,et al. Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] T. van Mieghem,et al. Updated Manufacturer and European Medicines Agency Recommendations on the Use of Mycophenolate Acid: Balancing the Risks for Male Allograft Recipients. , 2016, Transplantation.
[23] D. Hesselink,et al. Belatacept: A Game Changer? , 2016, Transplantation.
[24] Michael E. Sutton,et al. Normothermic machine perfusion reduces bile duct injury and improves biliary epithelial function in rat donor livers , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[25] Pedro M. Baptista,et al. How important is donor age in liver transplantation? , 2016, World journal of gastroenterology.
[26] K. Dumon,et al. Endoscopic treatments of obesity: a comprehensive review. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[27] Bradley C Martin,et al. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. , 2016, Journal of the American Pharmacists Association : JAPhA.
[28] H. Putter,et al. Flushing the liver with urokinase before transplantation does not prevent nonanastomotic biliary strictures , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[29] Christine A. White,et al. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. , 2016, The lancet. Diabetes & endocrinology.
[30] F. Thaiss,et al. Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation. , 2016, Transplantation reviews.
[31] E. Manias,et al. A compilation of consumers' stories: the development of a video to enhance medication adherence in newly transplanted kidney recipients. , 2016, Journal of advanced nursing.
[32] G. Verleden,et al. Testing the Efficacy of a Multicomponent Theory-Based Tailored Behavioral Medication Adherence Intervention in Transplantation: The MAESTRO-TX RCT , 2016 .
[33] H. Tedesco-Silva,et al. Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant , 2016, Therapeutic drug monitoring.
[34] J. Reyes,et al. Impact of Cold Ischemia Time on Outcomes of Liver Transplantation: A Single Center Experience. , 2016, Annals of transplantation.
[35] B. Nemes,et al. Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors , 2016, Expert review of gastroenterology & hepatology.
[36] D. Samuel,et al. Repeat liver retransplantation: rationale and outcomes , 2016, Clinical transplantation.
[37] F. Schena,et al. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? , 2016, Journal of Nephrology.
[38] G. Klintmalm,et al. Proposed Diagnostic Criteria for Chronic Antibody‐Mediated Rejection in Liver Allografts , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] F. Thaiss,et al. Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid , 2016, Transplant infectious disease : an official journal of the Transplantation Society.
[40] J. Layden,et al. Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review , 2016, Transplant infectious disease : an official journal of the Transplantation Society.
[41] B. Bikbov,et al. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus , 2016, Clinical kidney journal.
[42] L. Rostaing,et al. Belatacept and Long-Term Outcomes in Kidney Transplantation. , 2016, The New England journal of medicine.
[43] D. Kuypers,et al. Clinical determinants of calcineurin inhibitor disposition: a mechanistic review , 2016, Drug metabolism reviews.
[44] M. Nguyen,et al. Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis , 2016, BMJ open gastroenterology.
[45] G. Tydén,et al. A Prospective Randomized Trial on the Effect of Using an Electronic Monitoring Drug Dispensing Device to Improve Adherence and Compliance , 2016, Transplantation.
[46] H. Tedesco-Silva,et al. Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals , 2015, PloS one.
[47] L. Potena,et al. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients , 2015, Transplantation.
[48] V. Mazzaferro,et al. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial , 2015, Transplantation.
[49] G. Lucchetti,et al. Stress, coping and adherence to immunosuppressive medications in kidney transplantation: a comparative study , 2015, Sao Paulo medical journal = Revista paulista de medicina.
[50] H. Hirsch,et al. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP‐12 , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[51] David D. Lee,et al. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. , 2015, Annals of hepatology.
[52] L. Rostaing,et al. De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[53] B. Hoppe,et al. Transitional Care and Adherence of Adolescents and Young Adults After Kidney Transplantation in Germany and Austria , 2015, Medicine.
[54] O. Thaunat. Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression. , 2015, Kidney international.
[55] L. VanWagner,et al. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[56] Fernando Antônio Basile Colugnati,et al. Multilevel Correlates of Non-Adherence in Kidney Transplant Patients Benefitting from Full Cost Coverage for Immunosuppressives: A Cross-Sectional Study , 2015, PloS one.
[57] V. Cicinnati,et al. Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors. , 2015, Annals of transplantation.
[58] M. de Zwaan,et al. Physician reported adherence to immunosuppressants in renal transplant patients: Prevalence, agreement, and correlates. , 2015, Journal of psychosomatic research.
[59] K. Watt. Keys to long-term care of the liver transplant recipient , 2015, Nature Reviews Gastroenterology &Hepatology.
[60] Deepanshu Jain,et al. Endoscopic Bypass Using Endobarrier Devices: Efficacy in Treating Obesity and Metabolic Syndrome , 2015, Journal of clinical gastroenterology.
[61] A. Rule,et al. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics. , 2015, Clinical chemistry.
[62] P. Burra,et al. Neoplastic disease after liver transplantation: Focus on de novo neoplasms. , 2015, World journal of gastroenterology.
[63] I. Bilbao,et al. Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients , 2015, Clinical transplantation.
[64] W. Weimar,et al. Young Adult Kidney Transplant Recipients: Nonadherent and Happy , 2015, Transplantation.
[65] T. Lazzarotto,et al. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial , 2015, Transplantation.
[66] R. Snanoudj,et al. Immunological risks of minimization strategies , 2015, Transplant International.
[67] P W Nickerson,et al. The Synergistic Effect of Class II HLA Epitope‐Mismatch and Nonadherence on Acute Rejection and Graft Survival , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[68] R. Hirose,et al. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. , 2015, The New England journal of medicine.
[69] R. Porte,et al. Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions. , 2015, Journal of hepatology.
[70] J. Heimbach,et al. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[71] F. Nevens,et al. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study , 2015, Transplantation.
[72] C. Elie,et al. Prevalence and Predictors of Early Cardiovascular Events after Kidney Transplantation: Evaluation of Pre-Transplant Cardiovascular Work-Up , 2015, PloS one.
[73] G. Knoll,et al. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis , 2015, BMJ : British Medical Journal.
[74] J. Dumonceau,et al. Endoscopic management of biliary complications after liver transplantation: An evidence-based review. , 2015, World journal of gastrointestinal endoscopy.
[75] M. Schilsky,et al. Review on immunosuppression in liver transplantation. , 2015, World journal of hepatology.
[76] A. Demetris,et al. ABO-compatible liver allograft antibody-mediated rejection: an update , 2015, Current opinion in organ transplantation.
[77] M. Nicholson,et al. Normothermic machine perfusion of the kidney: better conditioning and repair? , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[78] L. Rostaing,et al. Fibrosis Progression According to Epithelial‐Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[79] M. Gonçalves,et al. Metabolic profile and cardiovascular risk in a population of renal transplant recipients. , 2015, Transplantation proceedings.
[80] D. Hesselink,et al. Mycophenolate revisited , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[81] D. Hesselink,et al. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. , 2015, Transplantation reviews.
[82] D. Samuel,et al. From immunosuppression to tolerance. , 2015, Journal of hepatology.
[83] A. Henning,et al. Interleukin-2 Receptor Antagonist Therapy Leads to Increased Tacrolimus Levels After Kidney Transplantation , 2015, Therapeutic drug monitoring.
[84] D. Seehofer,et al. Cardiovascular risk and events after liver transplantation. Experiences from 313 consecutive transplants with a follow‐up of 20 years , 2015, Clinical transplantation.
[85] G. Klintmalm,et al. Impact of IgG3 Subclass and C1q‐Fixing Donor‐Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[86] T. Lim,et al. Preoperative coronary calcium score is predictive of early postoperative cardiovascular complications in liver transplant recipients. , 2015, British journal of anaesthesia.
[87] G. Divine,et al. Incidence of cardiovascular and cerebrovascular events associated with sirolimus use after liver transplantation. , 2015, Transplantation proceedings.
[88] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[89] J. Bargehr,et al. Preexisting atrial fibrillation and cardiac complications after liver transplantation , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[90] A. Åsberg,et al. Use of Generic Tacrolimus in Elderly Renal Transplant Recipients: Precaution Is Needed , 2015, Transplantation.
[91] R. Steadman,et al. Postoperative Atrial Fibrillation in Liver Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[92] U. Settmacher,et al. Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[93] D. Sawinski,et al. BK virus infection: an update on diagnosis and treatment. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[94] W. Weimar,et al. Discrepancies Between Beliefs and Behavior: A Prospective Study Into Immunosuppressive Medication Adherence After Kidney Transplantation , 2015, Transplantation.
[95] J. Scoazec,et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. , 2015, Journal of the American Society of Nephrology : JASN.
[96] P. Bachellier,et al. Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[97] A. Jardine,et al. Cardiovascular morbidity and mortality after kidney transplantation , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[98] J. Tredger,et al. Performance of modified‐release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[99] J. Emond,et al. Hypothermic Machine Preservation Facilitates Successful Transplantation of “Orphan” Extended Criteria Donor Livers , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[100] A. Shirali,et al. Drug-induced impairment of renal function , 2014, International journal of nephrology and renovascular disease.
[101] David D. Lee,et al. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[102] Jennifer Wu,et al. Mammalian target of rapamycin inhibition in hepatocellular carcinoma. , 2014, World journal of hepatology.
[103] G. Knoll,et al. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data , 2014, BMJ : British Medical Journal.
[104] M. Abecassis,et al. High early cardiovascular mortality after liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[105] W. Robiner,et al. Predictive Patterns of Early Medication Adherence in Renal Transplantation , 2014, Transplantation.
[106] R. Annunziato,et al. Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[107] O. Manuel,et al. Cytomegalovirus infection in solid organ transplant recipients. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[108] G. Russ,et al. A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[109] A. Berrebi,et al. Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen alloimmunization risk. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[110] A. Grassi,et al. Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem. , 2014, World journal of gastroenterology.
[111] Lin Zhou,et al. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. , 2014, World journal of gastroenterology.
[112] R. Razonable,et al. Cytomegalovirus infection in liver transplant recipients: updates on clinical management. , 2014, World journal of gastroenterology.
[113] E. Björnsson,et al. Pre-Transplant Renal Impairment Predicts Posttransplant Cardiac Events in Patients With Liver Cirrhosis , 2014, Transplantation.
[114] F. Carrilho,et al. Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. , 2014, World journal of gastroenterology.
[115] T. Therneau,et al. Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[116] E. Paz-Artal,et al. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation , 2014, Transplant international : official journal of the European Society for Organ Transplantation.
[117] S. Knight,et al. The Effect of Preservation Solutions for Storage of Liver Allografts on Transplant Outcomes: A Systematic Review and Meta-Analysis , 2014, Annals of surgery.
[118] P. T. Coates,et al. The immune phenotype may relate to cancer development in kidney transplant recipients. , 2014, Kidney international.
[119] L. Berben,et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post‐transplant and determining pretransplant medication nonadherence as risk factor for post‐transplant nonadherence to immunosuppressives: The Swiss Transplant Cohort Study , 2014, Transplant international : official journal of the European Society for Organ Transplantation.
[120] D. Hauschke,et al. Telemedical Supported Aftercare as an Innovative Project-Study Improves the Quality of Life After Living Kidney Transplantation - A Single Center Experience.: Abstract# D2730 , 2014 .
[121] T. Cvetković,et al. Immunosuppressive Medication Adherence in Kidney Transplant Patients , 2014, Medical Principles and Practice.
[122] G. Klintmalm,et al. Donor‐specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[123] S. Kim,et al. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. , 2014, Kidney international.
[124] E. Manias,et al. Medicine non-adherence in kidney transplantation. , 2014, Journal of renal care.
[125] T. Gelder. Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation , 2014 .
[126] G. Opelz,et al. Renin-Angiotensin system blockers and cardiovascular death in kidney recipients. , 2014, Transplantation.
[127] J. O’Beirne,et al. Generic tacrolimus in solid organ transplantation , 2014, Clinical transplantation.
[128] I. Wilding,et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. , 2014, Clinical therapeutics.
[129] W. Weimar,et al. Attitudes to Medication after Kidney Transplantation and Their Association with Medication Adherence and Graft Survival: A 2-Year Follow-Up Study , 2014, Journal of transplantation.
[130] S. Stewart,et al. Validity of Cardiovascular Risk Prediction Models in Kidney Transplant Recipients , 2014, TheScientificWorldJournal.
[131] Rajan K. Patel,et al. Cardiovascular complications after transplantation: treatment options in solid organ recipients. , 2014, Transplantation reviews.
[132] B. Müllhaupt,et al. HOPE for human liver grafts obtained from donors after cardiac death. , 2014, Journal of hepatology.
[133] G. Klintmalm,et al. The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[134] L. Rostaing,et al. Prevalence, Incidence and Risk Factors for Donor‐Specific Anti‐HLA Antibodies in Maintenance Liver Transplant Patients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[135] J. Zaltzman,et al. A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity , 2014, Transplantation research.
[136] A. Sharif,et al. Death within the first year after kidney transplantation – an observational cohort study , 2014, Transplant international : official journal of the European Society for Organ Transplantation.
[137] Yannan Jiang,et al. Additive effect of pretransplant obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[138] Michael E. Sutton,et al. Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death , 2014, PloS one.
[139] F. Durand,et al. Determination of the Most Influential Sources of Variability in Tacrolimus Trough Blood Concentrations in Adult Liver Transplant Recipients: A Bottom-Up Approach , 2014, The AAPS Journal.
[140] F. Lehner,et al. Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation , 2014, Journal of clinical medicine research.
[141] Deepali Kumar,et al. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation , 2014, Clinical & translational immunology.
[142] P. Aslani,et al. Assessing medication adherence: options to consider , 2014, International Journal of Clinical Pharmacy.
[143] C. Kubal,et al. Crossmatch-Positive Liver Transplantation in Patients Receiving Thymoglobulin-Rituximab Induction , 2014, Transplantation.
[144] G. Pacini,et al. Efficacy and Safety of Vildagliptin in New‐Onset Diabetes After Kidney Transplantation—A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[145] C. Polidori,et al. Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients. , 2013, World journal of gastroenterology.
[146] M. Christiaans,et al. Lower Variability in 24-Hour Exposure During Once-Daily Compared to Twice-Daily Tacrolimus Formulation in Kidney Transplantation , 2013, Transplantation.
[147] V. Paradis,et al. Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. , 2013, Journal of hepatology.
[148] A. Burroughs,et al. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. , 2013, Journal of hepatology.
[149] D. Nelson,et al. Patient-Reported Immunosuppression Nonadherence 6 to 24 Months after Liver Transplant: Association with Pretransplant Psychosocial Factors and Perceptions of Health Status Change , 2013, Progress in transplantation.
[150] G. Opelz,et al. Cardiovascular Death in Kidney Recipients Treated With Renin–Angiotensin System Blockers , 2013, Transplantation.
[151] P. Clavien,et al. Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation. , 2013, Journal of hepatology.
[152] D. Roelen,et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients , 2013, Hepatology.
[153] L. Rostaing,et al. Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[154] M. Charlton. How important is acute cellular rejection? , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[155] J. O'grady,et al. Immunosuppression minimization vs. complete drug withdrawal in liver transplantation. , 2013, Journal of hepatology.
[156] J. Fishman. Opportunistic infections--coming to the limits of immunosuppression? , 2013, Cold Spring Harbor perspectives in medicine.
[157] M. Lucey,et al. Pretransplant donor‐specific anti‐HLA antibodies as predictors of early allograft rejection in ABO‐compatible liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[158] M. Guba,et al. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients , 2013, Transplant international : official journal of the European Society for Organ Transplantation.
[159] D. Slakey,et al. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation. , 2013, Transplantation reviews.
[160] O. Kwon,et al. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants? , 2013, Transplantation proceedings.
[161] X. Jouven,et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.
[162] P. Nickerson,et al. Rejection: An Integrated Response , 2013, American Journal of Transplantation.
[163] P. Harden,et al. Optimal management of young adult transplant recipients: the role of integrated multidisciplinary care and peer support , 2013, Annals of Saudi Medicine.
[164] G. Klintmalm,et al. Preformed class II donor‐specific antibodies are associated with an increased risk of early rejection after liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[165] Jeannie K. Lee,et al. Improving Outcomes of Renal Transplant Recipients With Behavioral Adherence Contracts: A Randomized Controlled Trial , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[166] M. Lucan,et al. Immunosuppression in kidney transplantation , 2013, Clujul medical.
[167] A. Gaber,et al. Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients , 2013, Transplantation.
[168] L. van Dijk,et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions , 2013, Patient preference and adherence.
[169] A. Sharif,et al. Delayed graft function after kidney transplantation: the clinical perspective. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[170] W. Chapman,et al. Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[171] S. Knight,et al. Systematic review and meta‐analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes , 2013, The British journal of surgery.
[172] A. Frigo,et al. Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study , 2013, Transplantation.
[173] M. Salvadori,et al. Is it time to give up with calcineurin inhibitors in kidney transplantation? , 2013, World journal of transplantation.
[174] G. Klintmalm,et al. De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[175] A. Kukla,et al. Calcineurin Inhibitor Nephrotoxicity: A Review and Perspective of the Evidence , 2013, American Journal of Nephrology.
[176] R. Fontana,et al. Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[177] A. Şener,et al. Renal perfusion pump vs cold storage for donation after cardiac death kidneys: a systematic review. , 2013, The Journal of urology.
[178] S. Teramukai,et al. Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation , 2013, Clinical & developmental immunology.
[179] A. S. Lima,et al. Incidence and risk factors for diabetes, hypertension and obesity after liver transplantation. , 2013, Nutricion hospitalaria.
[180] M. Chisholm-Burns,et al. Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population? , 2013, Patient preference and adherence.
[181] M. Hebert,et al. Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum , 2013, Transplantation.
[182] A. Salim,et al. The Impact of Meeting Donor Management Goals on the Development of Delayed Graft Function in Kidney Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[183] B. Kiberd. Colorectal cancer screening in kidney disease patients: working backwards. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[184] J. D. de Fijter,et al. Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[185] A. Patat,et al. The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers , 2013, European Journal of Clinical Pharmacology.
[186] L. Mandarino,et al. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. , 2013, Transplantation.
[187] P. Randhawa,et al. BK Polyomavirus in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[188] G. Knoll,et al. Evaluation of a collaborative chronic care approach to improve outcomes in kidney transplant recipients , 2013, Clinical transplantation.
[189] E. Paz-Artal,et al. Hypocomplementemia in Kidney Transplant Recipients: Impact on the Risk of Infectious Complications , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[190] M. Volk,et al. Non-Adherence and Graft Failure in Adult Liver Transplant Recipients , 2013, Digestive Diseases and Sciences.
[191] C. Haisch,et al. Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts , 2013, Transplantation.
[192] A. Burroughs,et al. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. , 2013, Journal of hepatology.
[193] W. Bechstein,et al. Recurrent hepatocellular carcinoma after liver transplantation – an emerging clinical challenge , 2013, Transplant international : official journal of the European Society for Organ Transplantation.
[194] R. Wiesner,et al. Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[195] J. Fishman. Overview: Cytomegalovirus and the Herpesviruses in Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[196] A. Vitale,et al. Use of N‐acetylcysteine during liver procurement: A prospective randomized controlled study , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[197] F. Saliba,et al. End of the Line for Sirolimus in Liver Transplant Recipients With Hepatitis C Virus? , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[198] Hermann Brenner,et al. Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes , 2013, Transplantation.
[199] F. Dobbels,et al. Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients: A Randomized Controlled Trial Using Electronic Monitoring , 2013, Transplantation.
[200] A. Webster,et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.
[201] G. L’italien,et al. The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials , 2013, Transplantation.
[202] J. Neuberger,et al. Long‐term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[203] B. Meiser,et al. Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis , 2012, Transplantation.
[204] M. Hebert,et al. Pharmacokinetics of Tacrolimus During Pregnancy , 2012, Therapeutic drug monitoring.
[205] J. Patard,et al. De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[206] W. Chapman,et al. Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[207] M. Salvadori,et al. Renal transplant allocation criteria, desensitization strategies and immunosuppressive therapy in retransplant renal patients. , 2012, Journal of nephrology.
[208] J. Feinglass,et al. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events , 2012, Hepatology.
[209] S. Chadban,et al. The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients—A Systematic Review , 2012, Transplantation.
[210] A. Burroughs,et al. Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta‐Analysis , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[211] E. Paz-Artal,et al. Monitoring of Immunoglobulin Levels Identifies Kidney Transplant Recipients at High Risk of Infection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[212] G. MacGregor,et al. Reducing salt intake to prevent hypertension and cardiovascular disease. , 2012, Revista panamericana de salud publica = Pan American journal of public health.
[213] M. Costa,et al. Is liver transplantation a risk factor for cardiovascular disease? a meta‐analysis of observational studies , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[214] A. Demetris. Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance , 2012 .
[215] C. Bellamy. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[216] E. Raichlin,et al. Diastolic Dysfunction in Patients With End-Stage Liver Disease is Associated With Development of Heart Failure Early After Liver Transplantation , 2012 .
[217] M. Orloff,et al. Invasive fungal infections following liver transplantation: Incidence, risk factors, survival, and impact of fluconazole‐resistant Candida parapsilosis (2003‐2007) , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[218] P. Berloco,et al. Metabolic syndrome and cardiovascular risk after liver transplantation: a single-center experience. , 2012, Transplantation proceedings.
[219] M. Cooper,et al. Factors related to immunosuppressant medication adherence in renal transplant recipients , 2012, Clinical transplantation.
[220] F. Cosio,et al. Cardiovascular Consequences of New-Onset Hyperglycemia After Kidney Transplantation , 2012, Transplantation.
[221] Siddharth Singh,et al. Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. , 2012, Mayo Clinic proceedings.
[222] L. Riella,et al. Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[223] D. Corley,et al. Diabetes, Hypertension and Hyperlipidemia: Prevalence Over Time and Impact on Long‐Term Survival After Liver Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[224] B. Kasiske,et al. Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation , 2012, Journal of the American College of Cardiology.
[225] C. Fondevila,et al. Hypothermic Oxygenated Machine Perfusion in Porcine Donation After Circulatory Determination of Death Liver Transplant , 2012, Transplantation.
[226] F. Lehner,et al. A Randomized, Controlled Study to Assess the Conversion From Calcineurin‐Inhibitors to Everolimus After Liver Transplantation—PROTECT , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[227] N. Mueller,et al. Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients. , 2012, Transplantation.
[228] A. Loupy,et al. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure , 2012, Nature Reviews Nephrology.
[229] M. Stegall,et al. Prevalence, Course and Impact of HLA Donor‐Specific Antibodies in Liver Transplantation in the First Year , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[230] S. Hübscher. Antibody-mediated rejection in the liver allograft , 2012, Current opinion in organ transplantation.
[231] S. Shoham,et al. Invasive fungal infections in solid organ transplant recipients. , 2012, Future microbiology.
[232] P. Nickerson,et al. Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[233] K. Budde,et al. Donor‐Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[234] G. Russ,et al. Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[235] P. Schroder,et al. Can Immune Cell Function Assay Identify Patients at Risk of Infection or Rejection? A Meta-Analysis , 2012, Transplantation.
[236] R. Shapiro,et al. Antibody-Mediated Rejection in Kidney Transplantation: A Review , 2012, Journal of transplantation.
[237] Cheuk-Kwan Sun,et al. Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia–reperfusion injury in rats , 2012, Critical care medicine.
[238] G. Grosso,et al. Age is an important predictor of kidney transplantation outcome. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[239] A. Tura,et al. Early basal insulin therapy decreases new-onset diabetes after renal transplantation. , 2012, Journal of the American Society of Nephrology : JASN.
[240] A. Davenport,et al. Non-adherence to Immunosuppressive Medications in Kidney Transplantation: Intent Vs. Forgetfulness and Clinical Markers of Medication Intake , 2012, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[241] J. Cywinski,et al. CHALLENGES AND CONTROVERSIES IN LIVER TRANSPLANTATION Cumulative Risk of Cardiovascular Events After Orthotopic Liver Transplantation , 2012 .
[242] P. Burra. The adolescent and liver transplantation. , 2012, Journal of hepatology.
[243] J. Morales,et al. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain , 2012, Clinical transplantation.
[244] G. Noll,et al. Predicting intentions and adherence behavior in the context of organ transplantation: gender differences of provided social support. , 2012, Journal of psychosomatic research.
[245] M. Hill,et al. An Ecological Perspective on Medication Adherence , 2012, Western journal of nursing research.
[246] A. Matas,et al. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[247] V. Cicinnati,et al. Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[248] H. Schaefer. Long-Term Management of the Kidney Transplant Recipient , 2012, Blood Purification.
[249] M. Allison,et al. Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis , 2012, Gut.
[250] K. Budde,et al. Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal Transplantation , 2012, Drugs.
[251] Raymond Vanholder,et al. New-Onset Diabetes After Renal Transplantation , 2011, Diabetes Care.
[252] F. Dobbels,et al. Interventions Used by Health Care Professionals to Enhance Medication Adherence in Transplant Patients: A Survey of Current Clinical Practice , 2011, Progress in transplantation.
[253] T. Minor,et al. Hypothermic Reconditioning by Gaseous Oxygen Improves Survival After Liver Transplantation in the Pig , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[254] T. Gelder. European society for organ transplantation advisory committee recommendations on generic substitution of immunosuppressive drugs. , 2011 .
[255] T. van Gelder. European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[256] A. Sharif,et al. Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation. , 2011, Journal of the American Society of Nephrology : JASN.
[257] D. Brennan,et al. Delayed Graft Function in the Kidney Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[258] R. Wiesner,et al. Present state of immunosuppressive therapy in liver transplant recipients , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[259] D. Kuypers,et al. Diagnosis and prevention of chronic kidney allograft loss , 2011, The Lancet.
[260] A. Jardine,et al. Prevention of cardiovascular disease in adult recipients of kidney transplants , 2011, The Lancet.
[261] M. Yuen,et al. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. , 2011, Gastroenterology.
[262] Chi-hung Cheng,et al. Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients , 2011, Transplantation.
[263] G. Klintmalm,et al. High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[264] G. Verleden,et al. The spectrum of nonadherence with medication in heart, liver, and lung tranplant patients assessed in various ways , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[265] S. Hubscher. What is the long-term outcome of the liver allograft? , 2011 .
[266] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[267] K. Budde,et al. Biomarkers of Over‐Immunosuppression , 2011, Clinical pharmacology and therapeutics.
[268] X. Chen,et al. Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective , 2011, The Pharmacogenomics Journal.
[269] F. Gnoato,et al. Adherence in liver transplant recipients , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[270] S. Vowler,et al. The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom , 2011, Transplantation.
[271] S. Pham,et al. New onset diabetes after transplantation (NODAT): an overview , 2011, Diabetes, metabolic syndrome and obesity : targets and therapy.
[272] P. Piselli,et al. Metabolic syndrome and cardiovascular disease in kidney transplantation. , 2011, Transplantation proceedings.
[273] J. Woosley,et al. Liver allograft antibody‐mediated rejection with demonstration of sinusoidal C4d staining and circulating donor‐specific antibodies , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[274] A. Matas. Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[275] C. Cheadle,et al. rPSGL‐Ig for Improvement of Early Liver Allograft Function: A Double‐Blind, Placebo‐Controlled, Single‐Center Phase II Study † , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[276] A. Osband,et al. Extraction time of kidneys during organ procurement impacts function , 2011, Clinical transplantation.
[277] A. Cárdenas,et al. Current management of biliary complications after liver transplantation: emphasis on endoscopic therapy. , 2011, Gastroenterologia y hepatologia.
[278] Uwe Christians,et al. Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions , 2011, Expert opinion on drug metabolism & toxicology.
[279] R. Ploeg,et al. How important is the duration of the brain death period for the outcome in kidney transplantation? , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[280] D. Abramowicz,et al. Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study , 2010, Transplantation.
[281] O. Dirsch,et al. Release of Danger Signals during Ischemic Storage of the Liver: A Potential Marker of Organ Damage? , 2010, Mediators of inflammation.
[282] B. McCrindle,et al. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children , 2010, Pediatric transplantation.
[283] S. Saab,et al. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[284] M. Schnitzler,et al. A Risk Prediction Model for Delayed Graft Function in the Current Era of Deceased Donor Renal Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[285] W. Weimar,et al. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[286] M. Abecassis,et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[287] J. Neuberger,et al. Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[288] Dominique Charron,et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[289] E. Dodds-Ashley. Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients , 2010, Pharmacotherapy.
[290] F. Dobbels,et al. The Psychometric Properties and Practicability of Self-Report Instruments to Identify Medication Nonadherence in Adult Transplant Patients: A Systematic Review , 2010, Transplantation.
[291] R. Gaston,et al. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[292] L. Rostaing,et al. High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[293] K. Watt,et al. Metabolic syndrome and liver transplantation: a review and guide to management. , 2010, Journal of hepatology.
[294] G. Kazemier,et al. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[295] M. Cabello,et al. Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study , 2010, NDT plus.
[296] W. Kremers,et al. Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[297] J. Pascual,et al. Interaction Between Everolimus and Tacrolimus in Renal Transplant Recipients: A Pharmacokinetic Controlled Trial , 2010, Transplantation.
[298] R. Schmieder,et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[299] R. Wüthrich,et al. Non‐adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross‐sectional study , 2010, Clinical transplantation.
[300] F. Dobbels,et al. Immunosuppressive drugs and non-adherence in transplantation , 2010 .
[301] P. Terasaki,et al. Human leukocyte antigen crossmatch testing is important for liver retransplantation , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[302] A. Israni,et al. Predicting Coronary Heart Disease after Kidney Transplantation: Patient Outcomes in Renal Transplantation (PORT) Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[303] Deepali Kumar,et al. Guidelines for Vaccination of Solid Organ Transplant Candidates and Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[304] J. Neuberger. What is the real gain after liver transplantation? , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[305] M. Schnitzler,et al. Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[306] A. Burroughs,et al. Current management of hepatitis B virus infection before and after liver transplantation , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[307] F. Nevens,et al. Biliary strictures after liver transplantation: risk factors and prevention by donor treatment with epoprostenol. , 2009, Transplantation proceedings.
[308] K. Lopau,et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. , 2009, JAMA.
[309] J. Neuberger,et al. Late protocol liver biopsies in the liver allograft: A neglected investigation? , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[310] M. Chobanian,et al. New-onset diabetes after transplantation: a review of recent literature , 2009, Current opinion in organ transplantation.
[311] L. De Bleser,et al. Interventions to improve medication‐adherence after transplantation: a systematic review , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[312] P. Halloran,et al. Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[313] R. Lang,et al. Urokinase perfusion prevents intrahepatic ischemic-type biliary lesion in donor livers. , 2009, World journal of gastroenterology.
[314] J. Fernández-Real,et al. Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After Renal Transplantation , 2009, Transplantation.
[315] Zheng Wu,et al. Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study , 2009, European Journal of Clinical Pharmacology.
[316] P. Friend,et al. Normothermic Perfusion: A New Paradigm for Organ Preservation , 2009, Annals of surgery.
[317] M. Mangino,et al. Preservation methods for kidney and liver , 2009, Organogenesis.
[318] G. Verleden,et al. Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening , 2009, Transplantation.
[319] E. Gordon,et al. Medication‐taking among adult renal transplant recipients: barriers and strategies , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[320] R. Ploeg,et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. , 2009, The New England journal of medicine.
[321] K. D. de Jong,et al. Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk Factors , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[322] ET Morgan,et al. Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics , 2009, Clinical pharmacology and therapeutics.
[323] Minnie Sarwal,et al. Calcineurin Inhibitor Nephrotoxicity , 2012 .
[324] F. Dobbels,et al. Nonadherence Consensus Conference Summary Report , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[325] P. Neuhaus,et al. Methylprednisolone Therapy in Deceased Donors Reduces Inflammation in the Donor Liver and Improves Outcome After Liver Transplantation: A Prospective Randomized Controlled Trial , 2008, Annals of surgery.
[326] R. Formica,et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[327] Nina Singh,et al. Prevention of Posttransplant Cytomegalovirus Disease and Related Outcomes with Valganciclovir: A Systematic Review , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[328] M. Cendron. Antibiotic Prophylaxis in the Management of Vesicoureteral Reflux , 2008, Advances in urology.
[329] D. Kuypers,et al. Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring. , 2008, Annals of transplantation.
[330] G. Opelz,et al. Effect on Kidney Graft Survival of Reducing or Discontinuing Maintenance Immunosuppression After the First Year Posttransplant , 2008, Transplantation.
[331] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[332] A. Gurakar,et al. Biliary strictures following liver transplantation: Past, present and preventive strategies , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[333] J. Craig,et al. Cancer screening in renal transplant recipients: what is the evidence? , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[334] H. Meier‐Kriesche,et al. Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[335] A. Jevnikar,et al. Late kidney allograft loss: what we know about it, and what we can do about it. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[336] J. Steiger,et al. Diagnostic Accuracy of Measurement Methods to Assess Non‐Adherence to Immunosuppressive Drugs in Kidney Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[337] L. Rostaing,et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. , 2008, The New England journal of medicine.
[338] T. Nick,et al. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non‐adherence , 2008, Pediatric transplantation.
[339] P. Halloran,et al. Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.
[340] J. Fishman. Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.
[341] D. D’amico,et al. Liver transplantation using suboptimal grafts: Impact of donor harvesting technique , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[342] S. Doucette,et al. Renin Angiotensin System Blockade in Kidney Transplantation: A Systematic Review of the Evidence , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[343] G. Page,et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. , 2007, The Journal of clinical investigation.
[344] J. Magee,et al. Psychological Functioning, Nonadherence and Health Outcomes After Pediatric Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[345] G. Klintmalm,et al. Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity , 2007, Clinical transplantation.
[346] P. Morel,et al. Conversion to sirolimus‐based immunosuppression in maintenance liver transplantation patients , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[347] A. Abdo,et al. Liver transplantation for autoimmune hepatitis: a single-center experience. , 2007, Transplantation proceedings.
[348] J. Benner,et al. Adherence , 2007, Journal of clinical hypertension.
[349] Edward Cole,et al. Therapeutic monitoring of calcineurin inhibitors for the nephrologist. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[350] G. Gores,et al. Clinical Trial of the Pan‐Caspase Inhibitor, IDN‐6556, in Human Liver Preservation Injury , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[351] L. Rostaing,et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[352] P. Hayes,et al. Adherence to medication after liver transplantation in Scotland: A pilot study , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[353] J. Neuberger,et al. Life expectancy of adult liver allograft recipients in the UK , 2006, Gut.
[354] R. Malthaner,et al. Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation: A Meta‐Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[355] N. Yasui-Furukori,et al. Effect of grapefruit juice in relation to human pharmacokinetic study. , 2006, Current clinical pharmacology.
[356] A. Hartmann,et al. Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[357] G. Opelz,et al. Improved Long‐Term Outcomes After Renal Transplantation Associated with Blood Pressure Control , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[358] T. Pumarola,et al. Influence of Age in Renal Transplant Infections: Cases and Controls Study , 2005, Transplantation.
[359] F. Dobbels,et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[360] A. Zander,et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. , 2005, Kidney international.
[361] A. Webster,et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data , 2005, BMJ : British Medical Journal.
[362] S. Geest,et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[363] A. Jardine,et al. Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardiovascular Complications in Renal Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[364] U. Christians,et al. Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients , 2005, Alimentary pharmacology & therapeutics.
[365] T. Larson,et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. , 2005, Kidney international.
[366] L. Gesualdo,et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. , 2005, The New England journal of medicine.
[367] K. Nishimoto,et al. Increased tacrolimus trough levels in association with severe diarrhea, a case report. , 2004, Transplantation proceedings.
[368] T. Shimizu,et al. Analysis of cause of death with a functioning graft: a single-center experience. , 2004, Transplantation proceedings.
[369] M. Arias,et al. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[370] K. Arimori,et al. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[371] Anurag Maheshwari,et al. Post‐liver‐transplant anemia: Etiology and management , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[372] J. Chapman,et al. The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.
[373] R. Wolfe,et al. Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.
[374] E. Steyerberg,et al. Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids. , 2003, British journal of clinical pharmacology.
[375] T. Larson,et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. , 2003, Kidney international.
[376] H. Blom,et al. J Am Soc Nephrol 14: 1880–1888, 2003 Improved Cardiovascular Risk Profile and Renal Function in Renal Transplant Patients after Randomized Conversion from , 2022 .
[377] I. Holme,et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial , 2003, The Lancet.
[378] M. Ghoneim,et al. Death with Functioning Graft in Living Donor Kidney Transplantation: Analysis of Risk Factors , 2003, American Journal of Nephrology.
[379] Y. Sawada,et al. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient , 2003, Transplantation.
[380] G. Otto,et al. Prevention of ischemic‐type biliary lesions by arterial back‐table pressure perfusion , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[381] F. Delmonico,et al. Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.
[382] Bertram L Kasiske,et al. Diabetes Mellitus after Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[383] C. Murphy,et al. Successful Six‐Day Kidney Preservation Using Trophic Factor Supplemented Media and Simple Cold Storage , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[384] M. Rela,et al. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[385] R. Foley,et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. , 2002, Journal of the American Society of Nephrology : JASN.
[386] T. Theruvath,et al. Strategies to improve long-term outcomes after renal transplantation. , 2002, The New England journal of medicine.
[387] M. Kimikawa,et al. Effective oral administration of tacrolimus in renal transplant recipients , 2001, Clinical transplantation.
[388] E. Hochleitner,et al. Increased tacrolimus levels during diarrhea , 2001, Transplant international : official journal of the European Society for Organ Transplantation.
[389] I. Bekersky,et al. Comparative Tacrolimus Pharmacokinetics: Normal versus Mildly Hepatically Impaired Subjects , 2001, Journal of clinical pharmacology.
[390] P. Painter,et al. Physical activity and health‐related quality of life in liver transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[391] I. Bekersky,et al. Effect of Time of Meal Consumption on Bioavailability of a Single Oral 5 mg Tacrolimus Dose , 2001, Journal of clinical pharmacology.
[392] I. Bekersky,et al. Effect of Low‐ and High‐Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects , 2001, Journal of clinical pharmacology.
[393] O. Lambotte,et al. Interaction between theophylline and tacrolimus in a renal transplant patient. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[394] B. Kasiske,et al. Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[395] M. Kjaer,et al. Improved physical performance after orthotopic liver transplantation. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[396] S. Greenstein,et al. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. , 1998, Transplantation.
[397] R. Wiesner,et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome , 1998, Hepatology.
[398] Nina Singh,et al. Interactions between tacrolimus and antimicrobial agents. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[399] R. Calne. WOFIE hypothesis: some thoughts on an approach toward allograft tolerance. , 1996, Transplantation proceedings.
[400] D. Hunter,et al. Qualitative Research: Consensus methods for medical and health services research , 1995 .
[401] Mario Prost. System , 2019, Concepts for International Law.
[402] S. Saab,et al. Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients. , 2016, Gastroenterology & hepatology.
[403] H. Tedesco-Silva,et al. A prospective randomized trial investigating the influence of pharmaceutical care on the intraindividual variability of tacrolimus concentrations early after kidney transplant. , 2016, Therapeutic Drug Monitoring.
[404] X. Jouven,et al. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. , 2016, Journal of the American Society of Nephrology : JASN.
[405] A. Burroughs,et al. EASL Clinical Practice Guidelines: Liver transplantation. , 2016, Journal of hepatology.
[406] G. Opelz,et al. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. , 2014, Transplantation.
[407] R. Bruno,et al. Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF). , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[408] Zhihai Peng,et al. Association of hemoglobin levels, CYP3A5, and NR1I3 gene polymorphisms with tacrolimus pharmacokinetics in liver transplant patients. , 2014, Drug metabolism and pharmacokinetics.
[409] A. Caliendo,et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. , 2013, Transplantation.
[410] H. Mansell,et al. A retrospective study of the Framingham cardiovascular risk scores in a liver transplant population. , 2013, Transplantation proceedings.
[411] E. Reed,et al. Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. , 2013, Methods in molecular biology.
[412] J. Trotter,et al. Sirolimus--it doesn't deserve its bad Rap(a). , 2012, Journal of hepatology.
[413] H. Sasaki,et al. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. , 2012, Drug metabolism and pharmacokinetics.
[414] C. Watson,et al. Organ transplantation: historical perspective and current practice. , 2012, British journal of anaesthesia.
[415] S. Geest,et al. The economic implications of non-adherence after renal transplantation , 2012, PharmacoEconomics.
[416] Germaine Wong,et al. The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[417] S. Schinner. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .
[418] H. Bonatti. Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation , 2008 .
[419] G. Russ,et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.
[420] D. Samuel. Management of hepatitis B in liver transplantation patients. , 2004, Seminars in liver disease.
[421] T. Gelder. Drug Interactions with Tacrolimus , 2002 .